Predictions
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€157.00
12.12.20
12.12.20
-
12.12.21
12.12.21
-73.50%
10.08.21
10.08.21
American Renal Associates Holdings Inc
Start price
Target price
Perf. (%)
€9.35
12.12.20
12.12.20
-
12.12.21
12.12.21
0.00%
14.02.21
14.02.21
Envveno Medical Corp.
Start price
Target price
Perf. (%)
€10.03
12.12.20
12.12.20
€4.00
12.12.21
12.12.21
-45.01%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€2.30
12.12.20
12.12.20
€1.00
12.12.21
12.12.21
-14.22%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
Sonoma Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.90
12.12.20
12.12.20
€3.00
12.12.21
12.12.21
-8.48%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
Decining EBIT margin than peer group
EBIT decline > 20% expected
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€3.78
12.12.20
12.12.20
€2.00
12.12.21
12.12.21
4.76%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Establishment Labs Holdings Inc
Start price
Target price
Perf. (%)
€26.80
12.12.20
12.12.20
€7.00
12.12.21
12.12.21
153.73%
26.06.21
26.06.21
Aytu Biopharma Inc.
Start price
Target price
Perf. (%)
€105.00
12.12.20
12.12.20
€40.00
12.12.21
12.12.21
-15.81%
26.06.21
26.06.21
Nabriva Therapeutics plc
Start price
Target price
Perf. (%)
€52.18
12.12.20
12.12.20
€25.00
12.12.21
12.12.21
-42.50%
26.06.21
26.06.21
SELLAS Life Sciences Group Inc
Start price
Target price
Perf. (%)
€6.60
12.12.20
12.12.20
€3.00
12.12.21
12.12.21
63.18%
26.06.21
26.06.21
Rainforest Resources Inc.
Start price
Target price
Perf. (%)
€2.08
12.12.20
12.12.20
-
7.69%
15.12.20
15.12.20
Risky Investment
Business model of the past or high risk
Little known brand
Adyen NV ADR
Start price
Target price
Perf. (%)
€36.40
12.12.20
12.12.20
-
2.20%
15.12.20
15.12.20
Revenue growth >5% per year expected
Valuable balance sheet
Capable Management
Sequential Brands Group Inc.
Start price
Target price
Perf. (%)
€13.90
12.12.20
12.12.20
-
12.12.21
12.12.21
-61.51%
19.11.21
19.11.21
Piedmont Lithium Ltd. ADR
Start price
Target price
Perf. (%)
€22.20
12.12.20
12.12.20
-
12.12.21
12.12.21
119.82%
19.11.21
19.11.21